Product How it works Pricing Blog FAQ About Contact
Verastem

Verastem (NASDAQ: VSTM) revenue

Verastem reported revenue of $30.9m for fiscal 2025, 209.1% more than in fiscal 2024 ($10.0m). Since fiscal 2018 its revenue has grown by 15.7%, an average growth of 2.1% a year.

Verastem's best year of the last 7 was fiscal 2020. The biggest drop was in fiscal 2021, −97.7%.

Revenue, in millions of US dollars26.7201817.5201988.520202.120212.6202210.0202430.92025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$30.9m+209.1%−$170.1m−550.3%
2024$10.0m—−$115.0m−1,149.6%
2022$2.6m+26.4%−$72.9m−2,809.6%
2021$2.1m−97.7%−$61.4m−2,991.2%
2020$88.5m+407.1%−$49.4m−55.8%
2019$17.5m−34.7%−$132.3m−758.1%
2018$26.7m—−$94.8m−354.8%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Verastem revenue compared with its sector

By revenue for its latest fiscal year, Verastem ranks 350th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Verastem, 209.1%.

RankCompanyRevenueRevenue growth
348thStereotaxis$32.4m20.3%
349thEyePoint$31.4m−27.5%
350thVerastem$30.9m209.1%
351stFoghorn Therapeutics$30.9m36.8%
352ndEntrada Therapeutics$25.4m−87.9%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Verastem

How much revenue did Verastem make in fiscal 2025?
Verastem reported revenue of $30.9m for fiscal 2025, compared with $10.0m in fiscal 2024.
How much has the revenue of Verastem grown?
Between fiscal 2018 and fiscal 2025 it went from $26.7m to $30.9m: 15.7% more, an average growth of 2.1% a year.
What was the best year for revenue at Verastem?
Of its last 7 fiscal years, fiscal 2020, with $88.5m.
Where does Verastem rank in its sector by revenue?
It ranks 350th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Verastem come from?
From the annual report (Form 10-K) that Verastem files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Verastem files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2022 · 2021 · 2020 · 2019 · 2018. More on Verastem: the Verastem page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.